HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands

Molecular Membrane Biology

Volumn 16, Issue 1, 1999, Pages 49-55

  Clapham, Paul R ^a   Reeves, Jacqueline D ^a   Simmons, Graham ^a   Dejucq, Natalie ^a   Hibbitts, Sam ^a   McKnight, Áine ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

HIV receptors; HIV tropism

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; NEUTRALIZING ANTIBODY; VIRUS RECEPTOR;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL INTERACTION;

EID: 0032933633     PISSN: 09687688     EISSN: None     Source Type: Journal    
DOI: 10.1080/096876899294751     Document Type: Conference Paper

References (52)

1. Bagasra, O., Lavi, E., Bobroski, L., Khalili, K., Pestaner, J. P., Tawadros, R. and Pomerantz, R. J., 1996, Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS, 10, 573-585.
2. Berger, E. A., 1997, HIV entry and tropism: the chemokine receptor connection. AIDS, 11, S3-S16.
3. Berger, E. A., Doms, R. W., Fenyo, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J. and Weiss, R. A., 1998, A new classification for HIV-1. Nature, 391, 240.
4. Bieniasz, P. D., Fridell, R. A., Aramori, I., Ferguson, S. S., Caron, M. G. and Cullen, B. R., 1997, HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. Embo Journal, 16, 2599-2609.
5. Clapham, P. R., 1991, Human immunodeficiency virus infection of non-haematopoietic cells. The role of CD4-independent infection. Reviews in Medical Virology, 1, 51-58.
6. Clapham, P. R., 1997, HIV and chemokines: ligands sharing cell-surface receptors. Trends in Cell Biology, 7, 264-268.
7. - cells, J. Fantini and J.-M. Sabatier, Eds (ESCOM science publishers B. V., The Netherlands), Vol. 5, pp. 83-92.
8. Clapham, P. R., McKnight, A. and Weiss, R. A., 1992, Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. Journal of Virology, 66, 3531-3537.
9. Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O'Brien, S.J., 1996, Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science, 273, 1856-1862.
10. Delezay, O., Koch, N., Yahi, N., Hammache, D., Tourres, C., Tamalet, C. and Fantini, J., 1997, Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS, 11, 1311-1318.
11. Donzella, G. A., Schols, D., Lin, S. W., Este, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., De Clercq, E. and Moore, J. P., 1998, AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nature Medicine 4, 72-77.
12. Doranz, B. J., Grovit Ferbas, K., Sharron, M. P., Mao, S. H., Goetz, M. B., Daar, E. S., Doms, R. W. and O'Brien, W. A., 1997, A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. Journal Experimental Medicine, 186, 1395-1400.
13. Dragic, T., Trkola, A., Lin, S. W., Nagashima, K. A., Kajumo, F., Zhao, L., Olson, W. C., Wu, L., Mackay, C. R., Allaway, G. P., Sakmar, T. P., Moore, J. P. and Maddon, P. J., 1998, Aminoterminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. Journal of Virology, 72, 279-285.
14. Edinger, A. L., Amedee, A., Miller, K., Doranz, B. J., Endres, M., Sharron, M., Samson, M., Lu, Z. H., Clements, J. E., Murphey Corb, M., Peiper, S. C., Parmentier, M., Broder, C. C. and Doms, R. W., 1997, Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proceedings of the National Academy of Sciences USA, 94, 4005-4010.
15. Emerman, M., Bukrinsky, M. and Stevenson, M., 1994, HIV-1 infection of non-dividing cells. Nature, 369, 108.
16. Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau Haggarty, B., Choe, S., Vance, P. J., Wells, T. N., Power, C. A., Sutterwala, S. S., Doms, R. W., Landau, N. R. and Hoxie, J. A., 1996, CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell, 87, 745-756.
17. Fantini, J., Cook, D. G., Nathanson, N., Spitalnik, S. L. and Gonzalez Scarano, F., 1993, Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proceedings of the National Academy of Sciences USA, 90, 2700-2704.
18. Fear, W. R., Kesson, A. M., Naif, H., G.W., L. and Cunningham, A. L., 1998, Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. Journal of Virology, 72, 1334-1344
19. Guillon, C., van der Ende, M. E., Boers, P. H., Gruters, R. A., Schutten, M. and Osterhaus, A. D., 1998, Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities. Journal of Virology, 72, 6260-6263.
20. Harouse, J. M., Bhat, S., Spitalnik, S. L., Laughlin, M., Stefano, K., Silberberg, D. H. and Gonzalez Scarano, F., 1991, Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science, 253, 320-323.
21. Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., Kunstman, K., Erickson, D., Dragon, E., Landau, N. R., Phair, J., Ho, D. D. and Koup, R. A., 1996, The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine, 2, 1240-1243.
22. Hwang, S. S., Boyle, T. J., Lyerly, H. K. and Cullen, B. R., 1991, Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 253, 71-74.
23. Karita, E., Nkengasong, J. N., Willems, B., Vanham, G., Fransen, K., Heyndrickx, L., Janssens, W., Piot, P. and van der Groen, G., 1997, Macrophage-tropism of HIV-1 isolates of different genetic subtypes. AIDS, 11, 1303-1304.
24. Kledal, T. N., Rosenkilde, M. M., Coulin, F., Simmons, G., Johnsen, A. H., Alouani, S., Power, C. A., Luttichau, H. R., Gerstoft, J., Clapham, P. R., Clark Lewis, I., Wells, T. N. C. and Schwartz, T. W., 1997, A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277, 1656-1659.
25. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. and Hendrickson, W. A., 1998, Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature, 393, 648-659.
26. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A. and Landau, N. R., 1996, Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86, 367-377.
27. Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., Wells, T. N., Schlondorff, D. and Proudfoot, A. E., 1998, Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. Journal of Experimental Medicine, 187, 1215-1224.
28. Martin, K. A., Wyatt, R., Farzan, M., Choe, H., Marcon, L, Desjardins, E., Robinson, J., Sodroski, J., Gerard, C. and Gerard, N. P., 1997, CD4-independent binding of SIV gp120 to rhesus CCR5. Science, 278, 1470-1473.
29. McKnight, A., Clapham, P. R. and Weiss, R. A., 1994, HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology, 201, 8-18.
30. McKnight, A., Dittmar, M. T., Moniz Periera, J., Ariyoshi, K., Reeves, J. D., Hibbitts, S., Whitby, D., Aarons, E., Proudfoot, A. E., Whittle, H. and Clapham, P. R., 1998, A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. Journal of Virology, 72, 4065-4071.
31. McKnight, A., Wilkinson, D., Simmons, G., Talbot, S., Picard, L., Ahuja, M., Marsh, M., Hoxie, J. A. and Clapham, P. R., 1997, Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. Journal of Virology, 71, 1692-1696.
32. Mondor, I., Ugolini, S. and Sattentau, Q. J., 1998, Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. Journal of Virology 72, 3623-3634.
33. Moore, J. P., Trkola, A. and Dragic, T., 1997, Co-receptors for HIV-1 entry. Current Opinion in Immunology, 9, 551-562.
34. Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., Kishimoto, T., Yamamoto, N. and Nagasawa, T., 1997, A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. Journal of Experimental Medicine, 186, 1389-1393.
35. Owen, S. M., Ellenberger, D., Rayfield, M., Wiktor, S., Michel, P., Grieco, M. H., Gao, F., Hahn, B. H. and Lal, R. B., 1998, Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. Journal of Virology, 72, 5425-5432.
36. Picard, L., Simmons, G., Power, C. A., Meyer, A., Weiss, R. A. and Clapham, P. R., 1997, Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. Journal of Virology, 71, 5003-5011.
37. Proudfoot, A. E. I., Wells, T. N. C. and Clapham, P. R., 1998, Chemokine receptors - future therapeutic targets for HIV? Biochemical Pharmacology, 57, in press.
38. Reeves, J. D., McKnight, A., Potempa, S., Simmons, G., Gray, P. W., Power, C. A., Wells, T., Weiss, R. A. and Talbot, S. J., 1997, CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology, 231, 130-134.
39. Saag, M. S., Holodniy, M., Kuritzkes, D. R., WA, O. B., Coombs, R., Poscher, M. E., Jacobsen, D. M., Shaw, G. M., Richman, D. D. and Volberding, P. A., 1996, HIV viral load markers in clinical practice. Nature Medicine, 2, 625-629.
40. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. and Parmentier, M., 1996, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722-725.
41. Schols, D., Struyf, S., Van Damme, J., Este, J. A., Henson, G. and De Clercq, E., 1997, Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. Journal of Experimental Medicine, 186, 1383-1388.
42. Schuitemaker, H., Kootstra, N. A., de Goede, R. E., de Wolf, F., Miedema, F. and Tersmette, M., 1991, Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. Journal of Virology, 65, 356-363.
43. Sharer, L. R., Saito, Y., Epstein, L. G. and Blumberg, B. M., 1994, Detection of HIV-1 DNA in pediatric AIDS brain tissue by two-step ISPCR. Advances in Neuroimmunology, 4, 283-285.
44. Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C. and Proudfoot, A. E., 1997, Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science, 276, 276-279.
45. Simmons, G., Reeves, J. D., McKnight, A., Dejucq, N., Hibbitts, S., Power, C. A., Aarons, E., Schols, D., Clercq, E. D., Proudfoot, A. E. I. and Clapham, P. R., 1998, CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages. Journal of Virology, 72, 8453-8457.
46. Simmons, G., Wilkinson, D., Reeves, J. D., Dittmar, M. T., Beddows, S., Weber, J., Carnegie, G., Desselberger, U., Gray, P. W., Weiss, R. A. and Clapham, P. R., 1996, Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. Journal of Virology 70, 8355-8360.
47. Sol, N., Ferchal, F., Braun, J., Pleskoff, O., Treboute, C., Ansart I. and Alizon, M., 1997, Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. Journal of Virology 71, 8237-8244.
48. Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng Mayer, C., Robinson, J., Maddon, P. J. and Moore, J. P., 1996, CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature, 384, 184-187.
49. Valentin, A., Albert, J., Fenyo, E. M. and Asjo, B., 1994, Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. Journal of Virology, 68, 6684-6689.
50. Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K. and Clapham, P. R., 1997, Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. Journal of Virology, 71, 6407-6415.
51. Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C. and Sodroski, J., 1996, CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature, 384, 179-183.
52. Zaitseva, M., Blauvelt, A., Lee, S., Lapham, C. K., Klaus-Kovtun, V., Mostowski, H., Manischewitz, J. and Golding, H., 1997, Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nature Medicine, 3, 1369-1375.